For the Inventor, By the Inventor

Enter assignee name

Germantown, MD, United States of America

Precigen, Inc.

USPTO Granted Patents = 29

CIPO Patents = 1

EPO Patents = 4

Trademarks = 14

Forward Citations = 16

Loading Chart...

Loading Chart...

46 inventors (with patents filed for the assignee):

Rutul R Shah (13 out of 13 patents)

Lily Yuin Chao (8 out of 8 patents)

James Kealey (8 out of 9 patents)

4. Xinhua Zhao (8 out of 32 patents)

5. Ramya Yarlagadda (7 out of 7 patents)

6. Mark Anton Held (6 out of 6 patents)

7. Na Trinh (6 out of 6 patents)

8. Kevin Lee Dietzel (6 out of 7 patents)

9. Cheryl G Bolinger (6 out of 6 patents)

10. Helen Sabzevari (5 out of 5 patents)

11. Simon Metenou (5 out of 5 patents)

12. Peter Emtage (4 out of 12 patents)

13. Tina Huynh (4 out of 6 patents)

14. Jeffrey Orth (4 out of 4 patents)

15. Matthias Helmut Schmalisch (4 out of 4 patents)

29 patents: Sort by Forward Citations

1. 12404306 - Human papillomavirus vaccines and uses of the same (2025-09-02),

2. 12275772 - ROR-1 specific chimeric antigen receptors and uses thereof (2025-04-14),

3. 12234465 - Methods and microorganisms for the fermentation of methane to multi-carbon compounds (2025-02-25),

4. 12234261 - Hepatitis B vaccines and uses of the same (2025-02-25),

5. 12194094 - Fusion constructs and methods of using thereof (2025-01-14),

6. 12180517 - Expression of novel cell tags (2024-12-31),

7. 12091667 - Molecular switches (2024-09-17),

8. 12060585 - Expression of novel cell tags (2024-08-13),

9. 12018310 - Methods and microorganisms for making 1,4-butanediol and derivatives thereof from C1 carbons (2024-06-25),

10. 11998618 - Frataxin expression constructs (2024-06-04),

11. 11981746 - MUC16 specific chimeric antigen receptors and uses thereof (2024-05-14),

12. 11976134 - MUC16 specific chimeric antigen receptors and uses thereof (2024-05-07),

13. 11946054 - Modulating expression of polypeptides via new gene switch expression systems (2024-04-02),

14. 11939584 - Methods and microorganisms for making 2,3-butanediol and derivatives thereof from C1 carbons (2024-03-26),

15. 11821019 - Biological production of multi-carbon compounds from methane (2023-11-21),

Precigen, Inc. is a biotechnology company that harnesses the power of synthetic biology to develop innovative solutions for comprehensive gene and cell therapy. With a mission to improve the lives of patients worldwide, Precigen focuses on creating transformative therapies for cancer, rare diseases, and other genetic disorders. Combining cutting-edge technology, advanced manufacturing, and deep scientific expertise, Precigen strives to make personalized medicine a reality by unlocking the full potential of precision medicine.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

29 Patents

#9 in Germantown, MD

#136 in Maryland

#11,235 in US

#21,869 in the World

Germantown, MD, United States of America

Precigen, Inc.

Forward Citations = 16

46 inventors:

Rutul R Shah (13 out of 13 patents)

Lily Yuin Chao (8 out of 8 patents)

James Kealey (8 out of 9 patents)

4. Xinhua Zhao (8 out of 32 patents)

5. Ramya Yarlagadda (7 out of 7 patents)

Please report any incorrect information to support@idiyas.com

Loading…